RT Journal Article T1 Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease. A1 Taxonera, Carlos A1 Ponferrada, Ángel A1 Bermejo, Fernando A1 Riestra, Sabino A1 Saro, Cristina A1 Martín-Arranz, María Dolores A1 Cabriada, José Luis A1 Barreiro-de Acosta, Manuel A1 de Castro, María Luisa A1 López-Serrano, Pilar A1 Barrio, Jesús A1 Suarez, Cristina A1 Iglesias, Eva A1 Argüelles-Arias, Federico A1 Ferrer, Isabel A1 Marín-Jiménez, Ignacio A1 Hernández-Camba, Alejandro A1 Bastida, Guillermo A1 Van Domselaar, Manuel A1 Martínez-Montiel, Pilar A1 Olivares, David A1 Alba, Cristina A1 Gisbert, Javier P A1 SEGURTB study group from GETECCU, K1 Crohn′s disease K1 Tuberculosis K1 anti-TNF K1 immunosuppressant K1 inflammatory bowel disease K1 steroid K1 tuberculin skin test K1 ulcerative colitis AB Sensitivity of tuberculin skin test [TST] during screening for latent tuberculosis infection [LTBI] is affected by steroid and/or immunosuppressant therapy. The aim of this study was to compare performance of the two-step TST in inflammatory bowel disease patients immediately before anti-tumour necrosis factor [TNF] therapy as part of routine screening for LTBI vs control patients when the TST was carried out at an early stage. In this multicentre prospective controlled study, we evaluated the performance of two-step TST with 5-mm threshold. Factors associated with TST results were determined by logistic regression. We evaluated 243 candidates for anti-TNF therapy and 337 control patients. Overall, 105 patients [18.1%] had an induration ≥ 5 mm in the first TST or in TST retest. LTBI was diagnosed in 25% of patients by TST retest. Twenty-eight [11.5%] anti-TNF group patients vs 77 [22.8%] control patients had a positive TST (odds ratio [OR] 0.44, 95% confidence interval [CI] 0.28-0.70; P The sensitivity of routine TST performed just before starting anti-TNF therapy is low. TST performed at an early stage enables screening in the absence of immunosuppressive treatment and thus maximises the diagnostic yield of TST for detecting LTBI. YR 2017 FD 2017 LK http://hdl.handle.net/10668/10990 UL http://hdl.handle.net/10668/10990 LA en DS RISalud RD Apr 5, 2025